Riskpilot← Back to searchSign inGet full accessEvolex AB
ABActiveOrg 5565386009Byvägen 12Legal activities · NACE 6910Est. 19971-4 employees
Revenue 2025
SEK 379K
EBITDA margin
53.0%
+301% vs 2024
Equity ratio
65.6%
Financial strength
Net profit 2025
SEK 180K
+280% vs 2024
| Revenue | SEK 379K | — |
| EBITDA | SEK 201K | +301% |
| Net profit | SEK 180K | +280% |
| Total assets | SEK 275K | +152% |
| Equity | SEK 180K | +80% |
| Employees | — | — |
Legal name
Evolex AB
Org number
5565386009
Legal form
Aktiebolag
NACE code
6910 · Legal activities
Founded
22 januari 1997
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva konsultverksamhet med inriktning på regelefterlevnad, kvalitets- och hållbarhetsfrågor samt juridiska tjänster. Bolaget ska även kunna tillhandahålla utbildning, rådgivning, projektledning, digitala tjänster och andra konsultuppdrag, inklusive inom logistik och relaterade områden, samt verksamhet som har naturlig anknytning till detta.
Address
Byvägen 12
Phone
+46737170935
Email
chriscasteus@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 139 | 6 | 0 | 0 | 379 |
| Staff expenses | — | — | — | — | −137 |
| EBITDA | 3 | 1 | — | −100 | 201 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 3 | 1 | 0 | −100 | 201 |
| Net financials | — | — | — | — | −0 |
| Profit before tax | 3 | 1 | 0 | −100 | 201 |
| Tax | −0 | −0 | — | — | −21 |
| Net profit | 3 | 1 | 0 | −100 | 180 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 313 | 297 | 100 | 109 | 275 |
| Equity | −5 | −5 | 100 | 100 | 180 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 319 | 301 | 0 | 9 | 95 |
| Total debt | 319 | 301 | — | 9 | 95 |
EBITDA margin
53.0%
This company
15.8%
Market median
+235% vs market
20212025
Equity ratio
65.6%
This company
38.2%
Market median
+72% vs market
20212025
Return on equity
100.1%
This company
18.4%
Market median
+444% vs market
20212025
Net profit margin
47.5%
This company
8.1%
Market median
+486% vs market
20212025
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20212025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Evolex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cecilia Unnérus | Deputy Board Member | 0 companies |
| Chris Castéus | Board of Directors | 0 companies |